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Xeroderma pigmentosum complementation group C
gene (XPC) encodes a protein of 125 kDa which is pres-
ent in a tight complex with a 58-kDa protein encoded by
the human homolog of the yeast RAD23 gene, HHR23B
(Masutani, C., Sugasawa, K., Yanagisawa, J., Sonoyama,
T., Ui, M., Enomoto, T., Takio, K., Tanaka, K., van der
Spek, P. J., Bootsma, D., Hoeijmakers, J. H. J., and
Hanaoka, F. (1994) EMBO J. 13, 1831–1843). The XPC-
HHR23B complex is required for excision of thymine
dimers from DNA in a human excision nuclease system
reconstituted from purified proteins. In order to under-
stand the role of the XPC-HHR23B complex in excision
repair, we have overexpressed each subunit alone and
the heterodimer in heterologous systems, purified them,
and characterized their biochemical properties. We find
that both XPC and the heterodimer bind DNA with high
affinity and UV-damaged DNA with slightly higher pref-
erence. Surprisingly, we find that the XPC subunit alone
is sufficient for reconstitution of the human excision
nuclease and that the HHR23B subunit has no detecta-
ble effect on the excision activity of the reconstituted
system.
Nucleotide excision repair is a general repair system which is
particularly suited for removing bulky DNA lesions such as
thymine dimers and cisplatin-d(GpG) diadducts (Friedberg et
al., 1995; Sancar, 1996). A defect in excision repair causes
xeroderma pigmentosum (XP)1 in humans. XP patients are
hypersensitive to sunlight and develop skin cancers at a young
age and at high frequency; some patients, in addition, exhibit
neurological symptoms (Cleaver and Kraemer, 1989). Proteins
encoded by seven XP genes, XPA through XPG, are required for
the dual incision (excision) step of nucleotide excision repair. In
addition to the proteins encoded by the XP genes, the ERCC1
protein, the replication protein RPA, and the multimeric tran-
scription factor TFIIH (two of the subunits are XPB and XPD)
are required for the dual incision (Mu et al., 1995, 1996; Guzder
et al., 1995b). Furthermore, upon purification of XPC comple-
menting activity, it was found that the 125-kDa protein en-
coded by XPC (Legerski and Peterson, 1992; Masutani et al.,
1994) was in a complex with a protein of 58 kDa which is highly
homologous to the yeast excision repair protein encoded by the
RAD23 gene (Watkins et al., 1993; Masutani et al., 1994). In
humans there are two genes with sequence homology to
RAD23, and these were named human homolog of RAD23 A
and B (HHR23A and HHR23B), respectively; only the protein
encoded by HHR23B is found in a complex with XPC protein
(Masutani et al., 1994).
Although XPC and HHR23B appear to be tightly bound and
the final purification step for XPC yields these two proteins in
1:1 stoichiometry (Masutani et al., 1994; Aboussekhra et al.,
1995; Mu et al., 1996), there was no genetic or biochemical data
from mammalian systems indicating that HHR23B is involved
in excision repair. To clarify the role of HHR23B in repair, we
expressed XPC and HHR23B, separately and in a complex
using baculovirus/insect cells and plasmid/Escherichia coli ex-
pression systems, purified these proteins, and characterized
them. We found that XPC and the XPC-HHR23B complex bind
to DNA nonspecifically and with relatively high affinity and to
UV-damaged DNA with slightly higher affinity. Both forms of
XPC are capable of complementing cell-free extracts of XP-C
mutants and are active in reconstituting excision nuclease
activity in a completely defined system. We conclude that with
naked DNA under our experimental conditions HHR23B does
not play a direct role in excision repair.
MATERIALS AND METHODS
Plasmid Construction and Baculovirus Stock Establishment—Two
constructs were used for protein expression in insect cells (Fig. 1A). For
p2Bac.XPC-HHR23B, a 1.8-kb SmaI-DraI fragment from
pUC19.HHR23B (Masutani et al., 1994) was subcloned into the p2Bac
vector (Invitrogen) at the PvuII site under the control of the PH pro-
moter (p2Bac.HHR23B), followed by subcloning of the 3.6-kb NotI frag-
ment from pBSIISK(1).XPC (Masutani et al., 1994) at the NotI site
under the control of the P10 promoter. For p2Bac.XPC, only the NotI
fragment was subcloned into the p2Bac vector. Sf21 cells were trans-
fected with either p2Bac.XPC-HHR23B or p2Bac.XPC using the Bacu-
loGold Transfection Kit (Pharmingen). Recombinant virus stocks were
established from single plaques and identified by polymerase chain
reaction (PCR) amplification of viral DNA using a combination of p2Bac
vector and gene-specific primers. Standard procedures (O’Reilly et al.,
1994) were used for cell culture and infection by recombinant baculo-
viruses as well as for amplification and titering of the virus stocks.
To express recombinant proteins in bacterial cells, two constructs
were used (Fig. 1B). For pHis.HHR23B, a 1.2-kb PCR fragment was
subcloned into pQE-30 (Qiagen). The PCR primers were designed to
introduce a 59-BamHI site while simultaneously deleting the first two
(Met-Gln) and substituting the 3rd and 4th amino acids (from Val-Thr
to Gly-Ser) and to generate a 39-SalI site beyond the stop codon. For
pMBP.XPC, a 2.5-kb PCR fragment was subcloned into pMAL-c2 (New
England Biolabs). Primers were designed to generate a blunt end at the
first ATG codon of pXPC-3 (Legerski and Peterson, 1992) and to intro-
duce a 39-SalI site beyond the stop codon. The insert was in-frame with
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malE sequences (data not shown), but only a truncated fusion protein
was produced. Therefore, the pMBP.XPC DNA was digested with Hin-
dIII and SalI; the 1.3-kb fragment was gel-purified, and ends were filled
in with the Klenow enzyme, recut with SalI, and subcloned into
pMAL-c2 creating pMBP.XPC(445C), which encodes the malE gene
fused in-frame to the 445 amino acids from the carboxyl terminus of
XPC.
Cell-free Extracts and Protein Purification—Mammalian cell-free ex-
tracts (CFE) were prepared from an XPC fibroblast line (patient 21RO,
GM00709A, NIGMS Human Mutant Cell Repository, Camden, NJ) and
from a rodent homolog of XPG (cell line UV135, CRL1867, ATCC
Respository, Rockville, MD). Extracts were prepared according to the
method of Manley et al. (1980), dialyzed into buffer A (25 mM Hepes-
KOH, pH 7.9, 0.1 M KCl, 12 mMMgCl2, 0.5 mM EDTA, 2 mM DTT, 12.5%
glycerol), and stored at 280 °C. For immunoblot analyses, extracts were
also prepared from XPC-1BE, GM02246B; XPC-3BE, GM02248B; XPC-
9BE, GM02498B; XPC-1MI, GM02634; XPV-PHBE, GM02449B; XPV-
115LO, GM02359. Protein concentrations were measured by the Brad-
ford method (Bradford, 1976) using reagents from Bio-Rad. The
polypeptides required for in vitro reconstitution of nucleotide excision
repair were purified, analyzed, and stored as described (Mu et al., 1995,
1996).
To prepare recombinant XPC, insect cells (Sf21) were infected with
baculoviral stocks at multiplicity of infection 5 15. Following a 41–43-h
incubation, extracts were prepared as described above and dialyzed into
buffer B (20 mM potassium phosphate, pH 7.5, 0.01% Triton X-100, 1
mM EDTA, 1 mM DTT, 10% glycerol) containing 0.15 or 0.3 M KCl.
Protein concentrations were determined as described, and expression of
recombinant proteins as well as purification was monitored by immu-
noblot analyses as described below.
For purification of recombinant XPC, CFE (20 mg) was applied to a
phosphocellulose P11 (Whatman) column (4 ml), washed with 40 ml of
buffer B containing 0.15 M KCl, and bound proteins were eluted with
buffer B containing 1.0 M KCl. The XPC fractions were pooled, adjusted
to 0.6 M KCl by dilution with buffer B, and applied to a single-stranded
DNA-cellulose (Sigma) column (5 ml). The column was washed with 15
ml of buffer B containing 0.6 M KCl, and bound proteins were eluted
with buffer B containing 1.5 M KCl. The XPC fractions were pooled,
dialyzed against buffer B containing 0.15 M KCl, and applied to a
DEAE-agarose (Bio-Rad) column (1 ml). XPC does not bind to this
column, and further purification is not achieved, but this chromato-
graphic step removes contaminating DNA which interferes with subse-
quent analyses. The flow-through fractions containing XPC were pooled
and stored at 280 °C.
For purification of the XPC-HHR23B complex, a similar scheme was
used with the following modifications. The CFE was dialyzed into buffer
B containing 0.3 M KCl, 24 mg were applied to a phosphocellulose
column (4 ml) which was washed with 25 ml of the same buffer, and
bound proteins were eluted as described above. The XPC-HHR23B-
containing fractions were pooled, adjusted to 0.3 M KCl by dilution with
buffer B, and applied to a single-stranded DNA cellulose (Sigma) col-
umn (5 ml); this column was washed with 5 ml of buffer B containing 0.3
M KCl, and bound proteins were eluted with a step gradient of 0.3–1.5
M KCl in buffer B, with highly purified XPC-HHR23B eluting at 0.9–1.2
M KCl. XPC-HHR23B fractions were pooled, dialyzed against buffer B
containing 0.3 M KCl, and applied to a DEAE-agarose (Bio-Rad) column
(3 ml) which was washed with buffer B containing 0.3 M KCl; fractions
were pooled and stored at 280 °C.
For purification of histidine-tagged HHR23B, E. coli strain
DH5aF9lacIq was transformed with pHis.HHR23B, and cells were
grown at 37 °C to A600 ;0.6 and induced for 4 h with isopropyl-1-thio-
b-D-galactopyranoside at 0.5 mM. The bacterial cells were collected,
washed with phosphate-buffered saline, treated with lysozyme at 1
mg/ml, and disrupted by sonication (8 3 15 s with a Branson Sonicator
set at maximum power). Clarified extract was obtained by centrifuga-
tion at 35,000 rpm (Beckman Ti60 rotor), and His-HHR23B was puri-
fied by Ni-NTA chromatography (Qiagen) according to the manufactur-
er’s directions. CFE (100 mg in 10 ml) was mixed with 10 ml of resin for
16 h at 4 °C, and then the CFE-resin mixture was poured into a column
(15 cm 3 1.5 cm). Following extensive washing with buffer C (50 mM
sodium phosphate, pH 6, 0.3 M NaCl, 10% glycerol), bound proteins
were eluted with a step gradient of 0.05 to 0.5 M imidazole in buffer C,
with His-HHR23B eluting at 0.15–0.3 M imidazole. His-HHR23B-con-
taining fractions were pooled, dialyzed into buffer A, and stored at
280 °C.
For purification of the MBP-XPC(445C) fusion protein, the initial
processing was as described above for His-HHR23B except the 4-h
induction was with 0.3 mM isopropyl-1-thio-b-D-galactopyranoside.
Clarified extract (200 mg in 150 ml) was applied to an amylose column
(5 ml, New England Biolabs), and the manufacturer’s directions were
followed for elution of fusion proteins with 10 mM maltose. MBP-
XPC(445C)-containing fractions were pooled, dialyzed into buffer A,
and stored at 280 °C.
Antiserum Production and Immunoblotting—Two antigens, MBP-
XPC(445C) and His-HHR23B, were used for the generation of anti-XPC
and anti-HHR23B antisera. The bacterially expressed proteins were
mixed with adjuvant (RIBI Immunochem Research, Inc.) and used to
immunize rabbits at 2–3-week intervals (0.5 mg of protein per injection)
with serum samples being collected after the second injection. These
antisera react with XPC and HHR23B, respectively, in immunoblot
analyses. For immunoblotting, proteins were separated by SDS-poly-
acrylamide gel electrophoresis and transferred to nitrocellulose mem-
branes (Schleicher and Schuell, Protran) using standard procedures for
electroblotting. Antigen-antibody complexes were detected using the
alkaline phosphatase method (Promega) or enhanced chemilumines-
cence (Amersham).
DNA Binding Assays—Several oligonucleotides were prepared for
the DNA binding assays, but all substrates within a particular category
were prepared in essentially the same manner. Approximately 50 pmol
of each oligonucleotide were 59-end-labeled with T4 polynucleotide ki-
nase (New England Biolabs) and [g-32P]ATP (7000 Ci/mmol; ICN).
Labeled oligonucleotides were either ethanol-precipitated alone (ss-
DNA) or in the presence of unlabeled complementary oligomers (ds-
DNA), and DNA was resuspended in annealing buffer (40 mM Tris, pH
7.4, 100 mM NaCl, 4 mM MgCl2). To obtain ds-DNA substrates, the
coprecipitated oligomers were heated at 90–95 °C for 5 min and slow
cooled to ,30 °C (about 3 h). Both ss- and ds-DNA were separated from
unincorporated [g-32P]ATP or nonhybridized complementary strands by
electrophoresis on 6–8% polyacrylamide gels, followed by electroelu-
tion, ethanol precipitation, and resuspension in annealing buffer. For
preparing damaged DNA, the DNA was irradiated with 4–5 kJ/m2
using a germicidal lamp (254 nm). DNA was stored at 4 °C in annealing
buffer and diluted just prior to use in binding buffer. The substrates
used (Table I) include (a) 64-nt labeled oligomer (ss-DNA), part of which
was annealed to 61-mer (oligo 2) to generate a 60-bp duplex (ds-DNA)
with a 1-base overhang at the 59 end and 4-base overhang at the 39 end,
(b) 45-nt labeled oligomer (ss-DNA), an aliquot of which was annealed
to 45-mer (oligo 4) to generate a 45-bp duplex (ds-DNA), (c) 30-nt
labeled oligomer (ss-DNA), half of which was annealed to 30-mer (oligo
6) to generate a 26-bp duplex (ds-DNA), with 4-base overhangs at both
the 59 and 39 ends, and (d) 20-nt labeled oligomer (ss-DNA), part of
which was annealed to 20-mer (oligo 8) to generate a 20-bp duplex
(ds-DNA).
For the binding assays, DNA (;0.3 nM) was mixed with the indicated
amounts of protein in 15 ml of binding buffer (30 mM Hepes-KOH, pH
7.9, 4 mM potassium phosphate, pH 7.5, 100 mM KCl, 3.2 mM MgCl2, 0.4
mM DTT, 0.3 mM EDTA, 0.002% Triton X-100, 2 mM ATP, 2% glycerol,
1 mg of bovine serum albumin). Following a 30-min incubation at 30 °C,
TABLE I
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glycerol was added to 7%, and the protein-DNA complexes were sepa-
rated by electrophoresis at a constant current of 25 mA at room tem-
perature using 5% polyacrylamide gels containing acrylamide/methyl-
enebisacrylamide at 30:1 in 50 mM Tris borate and 1 mM EDTA, pH 8.3.
The gels were autoradiographed for visual inspection and quantita-
tively analyzed with an Ambis systems scanner.
Repair Assays—The excision assay, utilizing internally labeled 140-
mer cholesterol-A substrate (Matsunaga et al., 1995; Mu et al., 1996) or
a thymine dimer (T,.T) was used to assay repair activity for comple-
mentation of XPC cell-free extracts by rXPC and rXPC-HHR23B or for
reconstitution of excision repair by either rXPC-HHR23B or rXPC 6
HHR23B. Briefly, for complementation, increasing amounts of CFE
(60–100 mg) were mixed with a constant amount of either rXPC or
rXPC-HHR23B and incubated for 60 min at 30 °C in 25 ml of excision
buffer (35 mM Hepes-KOH, pH 7.9, 8 mM Tris-HCl, pH 7.5, 66 mM KCl,
32 mM NaCl, 5.6 mM MgCl2, 0.8 mM DTT, 0.4 mM EDTA, 2 mM ATP,
0.0004% Triton X-100, 20 mM each of dATP, dCTP, dGTP, and dTTP, 0.2
mg/ml bovine serum albumin, and 2.9% glycerol). Then, the mixtures
were incubated with Proteinase K for 15 min at 37 °C, and the DNAwas
purified by phenol/phenol chloroform/ether extractions followed by eth-
anol precipitation, and the products were analyzed on 10% polyacryl-
amide sequencing gels. Similar conditions were used for the reconsti-
tution experiments, except highly purified proteins were used in place
of the mutant CFE and rXPC was compared with natural XPC (native,
heterodimer purified from HeLa CFE) under optimal reaction condi-
tions and under suboptimal conditions to test for the effect(s) of
HHR23B, and the repair reaction was for 2.5 h at 30 °C.
RESULTS
Purification of Recombinant XPC and XPC-HHR23B—We
attempted to overproduce XPC and HHR23B in E. coli, but
failed to express full-length XPC in E. coli either from its own
initiation codon or in the form of a fusion protein with maltose-
binding protein (MBP). Nevertheless, the MBP-XPC fusion pro-
tein containing the carboxyl-terminal 445 amino acids of XPC
was expressed and used for generating XPC antibodies used in
the present study.
To obtain functional recombinant XPC, we cloned the gene
into the baculovirus expression vector p2Bac (Invitrogen) ei-
ther alone or together with HHR23B. Additionally, HHR23B
was cloned into an E. coli expression plasmid. Fig. 1 shows the
plasmid constructs used in the current study. Full-length sol-
uble proteins were expressed with these constructs. The XPC
protein and XPC-HHR23B heterodimer were purified essen-
tially as described by Masutani et al. (1994). The HHR23B
FIG. 1. Plasmids for recombinant protein expression. Four con-
structs were used in this study. A, p2Bac.XPC and p2Bac.XPC-
HHR23B were used for the expression and purification of recombinant
proteins used in DNA binding and repair assays. B, protein expressed
with pHis.HHR23B was used for both of these assays as well as for
antisera production. Recombinant protein expressed with
pMBP.XPC(445C) was used only for the generation of antisera. RecSeq
indicates recombination sequences for integration into the viral ge-
nome; Amp is the ampicillin resistance gene, b-lactamase.
FIG. 2. Analysis of purified proteins. Polypeptides were separated
by electrophoresis through a 10% SDS-polyacrylamide gel and detected
by staining with Coomassie Brilliant Blue (A, lanes 1–3) or by immu-
noblot analysis with alkaline phosphatase reagents (B, lanes 4–6).
Lane 1, rXPC-HHR23B, 1.2 mg, and lane 4, 0.5 mg of the same fraction;
lane 2, 0.6 mg, and lane 5, 0.25 mg, of rXPC; lanes 3 and 6, 1.3 mg and
0.8 mg, respectively, of His-HHR23B.Numbers to the left show positions
of size markers (Life Technologies, Inc. 10-kDa protein ladder).
FIG. 3. Western blot analyses of XPC cell-free extracts (CFEs)
and purified protein fractions. Polypeptides were separated by elec-
trophoresis through a 10% SDS-polyacrylamide gel, transferred to ni-
trocellulose, and probed with antisera. A, immunoblot analysis (alka-
line phosphatase reagents) of CFEs from HeLa (lane 1), normal
lymphoblastoid (NL, lane 2), and normal fibroblast (NF, lane 3) cells
compared with CFEs from various XPC strains (lanes 4–8). Approxi-
mately 50 mg of CFE were resolved in lanes 1–8 and 0.5 mg of
his.HHR23B in lane 9. The large arrow indicates HHR23B while the
smaller, upper arrow indicates a slower-migrating, cross-reacting ma-
terial (X) unique to lymphoblastoid cells. B, immunoblot analysis (en-
hanced chemiluminescence) of purified proteins used in the types of
experiments illustrated in Fig. 6. Lane 1 contained 15 ng of TFIIH, 20
ng of XPG, and 20 ng of XPF-ERCC1. Lane 2 contained 5 ng of XPC-
HHR23B purified from HeLa cells. Lane 3 contained 20 ng of recombi-
nant HHR23B purified from E. coli.
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protein was expressed in soluble form and in full-length in E.
coli and was purified from E. coli by nickel-affinity chromatog-
raphy. Fig. 2 shows the analyses of purified proteins by Coo-
massie Blue staining and Western blotting.
Expression of HHR23B in XPCMutant Cell Lines—Since one
of the goals of this study was the investigation of the properties
of the XPC protein in the absence of HHR23B, we wished to
know whether or not the XP-C mutant cell-free extracts con-
tained HHR23B protein at normal or reduced levels. Cell-free
extracts from a variety of cell lines were tested by Western
blotting. Fig. 3A shows that XPCmutants have normal levels of
HHR23B. In fact, during purification of XPC complementing
activity from HeLa cells, we found that HHR23B is in vast
molar excess over the XPC polypeptide and separates from the
heterodimer readily by ion exchange chromatography.2
In addition, our purified repair factors were tested for the
presence of HHR23B to ascertain that factors other than the
XPC fraction were free of HHR23B, and, hence, complementa-
tion experiments done with recombinant XPC reflected the
activity of this subunit alone. Fig. 3B reveals that the repair
factors purified from HeLa cells contained no detectable
HHR23B (,0.2 ng per excision assay) and hence any activity
arising from the addition of XPC to the reconstituted system
could safely be ascribed to XPC alone.
DNA Binding Properties—The natural as well as the recom-
binant XPC-HHR23B were purified through DNA-cellulose af-
finity chromatography and hence were known to be DNA-bind-
ing proteins. For quantitative analysis of DNA binding
properties, we conducted electrophoretic mobility shift assays
with various types of DNAs. The heterodimer (both recombi-
nant and natural forms) binds to single-stranded and double-
stranded DNA (60-bp duplex) with comparable affinities (Fig.
4A) and with a KD of ;5 3 10
29 M (calculated from the 50%
binding point); heavily irradiated 60-bp duplex (about 3 pho-
tolesions per molecule) was bound with slightly higher affinity
(KD ;4 3 10
29 M, Fig. 4B). The heterodimer bound to the 45-bp
duplex with somewhat lower affinity and to a 26-bp duplex very
weakly; no binding with 20-bp oligomer could be detected over
the concentration range used (Fig. 4C); similar binding prop-
erties were observed when the probe was single-stranded DNA.
The HHR23B subunit on its own has no affinity for DNA (data
not shown). Interestingly, the XPC subunit binds the 60-bp
duplex with approximately 2-fold higher affinity than the het-
erodimer (Fig. 4D), suggesting that in fact HHR23B reduces
the intrinsic DNA binding affinity of XPC.
Reconstitution of Excision Nuclease with XPC-HHR23B and
with the XPC Polypeptide—Although mutations in XPC confer
sensitivity to DNA damage (Li et al., 1993), there is no genetic
evidence from mammalian systems implicating HHR23B in
repair. We wished to find out whether HHR23B plays a role in
repair by conducting complementation and reconstitution ex-
periments using the XPC polypeptide and the XPC-HHR23B2 C. P. Selby and A. Sancar, unpublished results.
FIG. 4. DNA binding by XPC and XPC-HHR23B. Assay conditions were as described under “Materials and Methods”; for A and B, the DNA
concentration was 0.3 nM and protein concentrations were as indicated. A, binding of rXPC-HHR23B to single-stranded 64-mer (ss-DNA) and
double-stranded 60-bp duplex (ds-DNA). Quantitative analyses of the data revealed that 50% binding was achieved with 4.8 nM and 5.2 nM XPC
with single- and double-stranded 60-mers, respectively. B, binding of rXPC-HHR23B to undamaged (2UV) and damaged (1UV) double-stranded
60-bp duplex. For UV-DNA, 4 nM gave 50% binding. C, binding of rXPC-HHR23B to single-stranded oligomers (20-mer, 30-mer, 45-mer, and
64-mer) and double-stranded duplexes (20 bp, 26 bp, 45 bp, and 60 bp). DNA concentration was 0.3 nM and rXPC-HHR23B was at 10.5 nM. At this
protein concentration, only 40% binding was observed with ss- or ds-45-mer, and 50% binding was estimated to be 13 nM. Less than 5% of 26-bp
duplex was bound, and no binding was detected for 30-mer or 20-mer (ss- and ds-DNA). D, binding of rXPC and XPC-HHR23B to 60-bp duplex.
DNA concentration was 0.3 nM and protein concentrations were as indicated; heterodimer used in this experiment was from its natural source
(HeLa cells). As with recombinant heterodimer, 50% binding was at 5.2 nM while rXPC bound 50% substrate at 2 nM. For all panels, the faster
migrating free DNA species is single-stranded DNA.
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heterodimer. We found that both forms are active in comple-
menting XP-C cell-free extracts (Fig. 5). This experiment,
which reveals that recombinant XPC is active in excision re-
pair, indicates that the XPC polypeptide made in the absence of
HHR23B folds properly. However, these experiments do not
show whether XPC can function without HHR23B because
XPC cells appear to have normal levels of HHR23B protein
(Fig. 3A) which could reconstitute the XPC-HHR23B het-
erodimer upon addition of XPC to the cell-free extract. To
address this particular question, we conducted experiments
with a defined system of purified excision repair proteins not
containing detectable levels of HHR23B (Fig. 3B). Fig. 6 shows
that XPC alone is sufficient to reconstitute the excision nucle-
ase to the same extent as the heterodimer purified from its
natural source (HeLa cells). Supplementing HHR23B to the
defined excision repair system reconstituted with XPC alone
did not alter the rate of excision.
A previous study (Mu et al., 1996) showed that a cholesterol
substitutent attached with a shorter linker to the phosphodi-
ester backbone (cholesterol-B) than the one used in the current
work (cholesterol-A) was excised normally even in the absence
of XPC-HHR23B. Therefore, it was conceivable that these ex-
cisions in the absence of HHR23B or even the XPC-HHR23B
complex were peculiar to these unnatural substrates. Hence,
we tested the classic substrate for human excision nuclease,
cyclobutane thymine dimer, in our reconstituted system. As
evident from Fig. 6, lanes 9 and 10, even the XPC polypeptide
alone is sufficient for reconstitution and there is no detectable
effect of HHR23B on excision under these experimental
conditions.
Thus, we conclude that HHR23B does not play a direct role
in excision repair but may modulate the XPC activity. Indeed,
HHR23B may have a negative effect on both DNA binding and
excision activity because we reproducibly observe better bind-
ing (Fig. 4D) and excision (Figs. 5 and 6) with rXPC alone
compared to the heterodimer.
DISCUSSION
The yeast RAD23 gene belongs to the RAD3 epistasis group,
whose members participate in excision repair. Null mutations
of genes in this group, such as RAD1, completely abolish exci-
sion repair (Prakash et al., 1993). In contrast, deletion of
RAD23 increases the UV sensitivity of yeast cells only modestly
(Perozzi and Prakash, 1986; Watkins et al., 1993) indicating
that, unlike RAD1 and other members of the RAD3 epistasis
group, RAD23 is not essential for excision. Thus, extrapolating
from yeast genetics, one would expect that the same would be
true in humans. However, even though the yeast and human
excision repair systems are highly homologous (Prakash et al.,
1993; Friedberg et al., 1995; Sancar, 1996), certain significant
differences have been found. In particular, it was found that
the 39 nick of the dual incision could occur in the absence of
XPF-ERCC1 in humans (Mu et al., 1996) but requires the
entire complement of excision repair proteins in yeast (Guzder
et al., 1995b). Thus, a priori, it was not possible to predict
whether XPC without HHR23B would be sufficient to reconsti-
tute the human excision nuclease. Indeed, it was reported that
it was not possible to separate XPC from HHR23B without
losing the XPC correcting activity (Masutani et al., 1994). The
results presented in this report indicate that the HHR23B
polypeptide is not required for the excision repair function of
the XPC protein and that HHR23B modulates XPC activity,
perhaps by interacting with and masking the DNA binding
domain of XPC. It is possible that the stringent conditions used
to separate XPC from HHR23B in the previous study inacti-
vated the XPC protein.
In light of our results, it is reasonable to ask whether
HHR23B plays any role in repair. To answer this question, in
addition to the yeast rad23 phenotype, one must take the
following findings into account. First, in humans, two RAD23
homologs were found which exhibit 57% sequence identity to
one another and 30–34% sequence identity to RAD23. Second,
of the two polypeptides, only HHR23B was found in a complex
with XPC (Masutani et al., 1994). Third, RAD23 (Watkins et
FIG. 5. Complementation of XPC mutant cell-free extracts by
rXPC and rXPC-HHR23B. rXPC-HHR23B (5 ng, lanes 3–5) or rXPC
(2. 5 ng, lanes 6–8) were added to the indicated amounts of XPC CFE
and tested for complementation of excision nuclease activity. Control
reactions are in lane 1 (50 mg of XPC 1 50 mg of XPG CFE) and lane 2
(100 mg of XPC CFE). The prominent 29-mer excision product is
indicated.
FIG. 6. Reconstitution of excision nuclease with rXPC and the
effect of rHHR23B. Assay conditions were as described under “Mate-
rials and Methods.” The amounts of XPC-HHR23B, rXPC, and
rHHR23B (his-tagged) are indicated, and other repair factors included
in all reaction mixtures were as follows: XPA, 25 ng; TFIIH, 2 ng; XPG,
4 ng; XPF-ERCC1, 9 ng; and RPA, 250 ng. The 29-mer excision product
is indicated.
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al., 1993) and HHR23 belong to the ubiquitin-fusion family of
proteins in that the NH2-terminal 80 amino acids are highly
homologous to ubiquitin (Masutani et al., 1994). The precise
role of ubiquitin in these proteins is not known but is thought
to function as a chaperone in assisting proper folding and
assembly and thermostability (Finley et al., 1989; Garrett et
al., 1994; Aso et al., 1995). Fourth, the Rad23 protein is not
essential for, but promotes complex formation between TFIIH
and Rad14 (XPA homolog) proteins (Guzder et al., 1995a). In
humans TFIIH seems to be directly bound to XPA without the
aid of other proteins (Park et al., 1995) although the possibility
that HHR23B stimulates XPA-TFIIH interaction has not been
ruled out. Fifth, the yeast homolog of XPC, the Rad4 protein, is
required for global excision repair (Prakash et al., 1993) but not
for excision repair of the transcribed strand of rDNA genes
which are transcribed by RNA polymerase I (Verhage et al.,
1996a). In contrast, in humans the template strand of the
polymerase II-transcribed sequences is repaired in XP-C mu-
tants at an essentially normal rate (Mellon et al., 1987; Kantor
et al., 1990; Venema et al., 1990, 1991; Evans et al., 1993). In
fact, it has been demonstrated in vitro that for certain lesions,
even in the absence of transcription, excision repair occurs
without XPC-HHR23B (Mu et al., 1996). Thus, not only
HHR23B but even XPC is dispensable for excision nuclease
activity under certain conditions or with certain substrates.
The following model is consistent with most of these obser-
vations. The HHR23B subunit of the heterodimer may be in-
volved in nucleosome disassembly or reorganization which
makes DNA accessible to the XPC subunit and other factors of
the excision nuclease system. Alternatively, HHR23B may
modulate the activity of XPC and perhaps function as a chap-
erone molecule. Indeed, preliminary experiments suggest that
HHR23B protects the XPC subunit from thermal inactivation
as tested by the DNA binding assay.3 The role of XPC may be
to stabilize the local unwinding that is thought to occur in the
preincision complex. Thus, with naked DNA (such as the 140-
mer substrate), there is no need for HHR23B. Similarly, in
transcribed DNA where local unwinding is provided by the
RNA polymerase stalled at a lesion or with certain lesions
which intrinsically cause local unwinding, XPC is not needed
and hence excision occurs at a near-normal rate in the absence
of the XPC-HHR23B heterodimer. This model is in agreement
with the finding of Miller et al. (1982) that yeast rad23mutants
removed pyrimidine dimers at about 60% of wild type levels. In
contrast, McCready (1994) and Verhage et al. (1996b) using
different methodologies did not find dimer removal from the
genome overall or from transcriptionally active genes in rad23
mutants. Further studies are needed to establish the function
of XPC, to determine whether there are bona fide differences
between the roles of HHR23B in humans and RAD23 in yeast,
and to reconcile these seemingly contradictory reports regard-
ing the requirement of RAD23 for excision repair in yeast.
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